Status: Not yet recruiting
ITX24-01 in Adult Male and Female Patients With Select Types of Severe Chronic Neck- and Lower Back Pain
The study is a single ascending dose (SAD), single-center, randomised, double-blind, placebo-controlled Phase 1b clinical trial designed to evaluate the safety, tolerability, and preliminary analgesic efficacy of ITX24-01 in patients with severe chronic zygapophysial joint pain (facet joint pain). The study consists of three dose escalation cohorts and one extension cohort.
Participants needed: 32
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Interventional AnalgesiX Inc.Updated: Apr 9, 2026Locations: 1
Eligibility criteria
Male or female. Women of childbearing potential must be willing to use contracep... [+7]
Pregnant or breastfeeding [+9]